A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care

Clinical trial NCT00071799 · COMPLETED

Trial details

NCT number: NCT00071799
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2003-11-01
Primary completion: 2007-07-01
Enrollment: 358

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.